Table 1.

Clinical data of hepatic epithelioid hemangioendothelioma patients

Patient	Age	Gender	Follow-up duration (months)	Number of tumor	Metastasis	Pathology	Treatment	Recurrence
1	35	Male	60	1	No	CD31(+), CD34(+), ERG(+), TFE-3(+), Ki67 (LI: approximately 5%)	LH	No
2	43	Male	48	2	Lymph nodes	CD31(+), CD34(+), ERG(+),PCK(+), Ki67 (LI: approximately 10%)	LH + RFA + lymphadenectomy	Yes
3	67	Female	48	1	No	CD31(+), CD34(+), ERG(+), TFE-3(+), Ki67 (LI: approximately 5%)	LH	No
4	41	Male	42	1	No		LH + RFA	No
5	28	Female	42	2	Lymph nodes	CD31(+), CD34(+), ERG(+), FLi-1(+), Ki67 (LI: <5%)	LH + lymphadenectomy	Yes
6	22	Male	36	1	No	CD31(+), CD34(+), ERG(+), Ki67 (LI: approximately 5%)	LH + Huaier granule	No
7	53	Male	36	2	No	CD31(+), CD34(+), ERG(+), PCK(+), Ki67 (LI: approximately 5%)	LH + sorafenib + Huaier granule	No
8	39	Female	24	1	No	CD31(+), CD34(+), ERG(+), FLi-1(+), Ki67 (LI: <5%)	LH	No
9	28	Male	12	3	Gallbladder	CD31(+), CD34(+), ERG(+), PCK(+), Ki67 (LI: approximately 5%)	LH + RFA + cholecystectomy + chemotherapy + sorafenib + Huaier granule	No
10	55	Female	12	2	Lymph nodes	CD31(+), CD34(+), ERG(+), Ki67 (LI: approximately 15%)	LH + RFA + lymphadenectomy + sorafenib + Huaier granule	No
11	55	Male	9	1	No	CD31(+), CD34(+), ERG(+), TFE-3(+), Ki67 (LI: approximately 5%)	LH + sorafenib + Huaier granule	No

LH laparoscopic hepatectomy, RFA radiofrequency ablation